The continued presence of the Omicron variant of COVID-19 has left the institutional investment industry with decisions on how to address a return to offices, in-person meetings and physical conferences in early 2022.
Some of the world’s greatest funds are exchanging toward emerging-market equities in a bet their central banks have less need to raise interest costs subsequent to fixing before their developed-nation peers a year ago.